cGMP Cell Therapy Facilities

RoslinCT Global Facilities

Our global facilities across two continents (North America and Europe) are purposely designed to deliver high-quality, cell-based therapy products with our partners from development to clinical and commercial manufacturing.

Empowering your cell therapy breakthroughs, globally:

Strategic locations in the hub of regenerative medicine: Boston, MA, and Edinburgh, Scotland
Close proximity to international airports which provide cost-effective logistics solutions
22 cGMP fully isolated processing suites allowing simultaneous processing of multiple clinical and/or commercial products with the opportunity for rapid expansion
Configurable Process, Analytical Development and Technology Transfer laboratories supporting our innovation efforts, and QC laboratories to ensure quality compliance from development to cGMP manufacturing
Our manufacturing facilities maintain cGMP-compliant quality systems

We hold a Manufacturer’s Authorization for Investigational Medicinal Products (MIA(IMP)) and a Manufacturer’s Authorization License (MIA) for commercial manufacturing of cell therapy products from the Medicines and Healthcare Products Regulatory Agency (MHRA)

Purpose-Built Facilities

While designing the facilities, RoslinCT’s experienced team, considered all aspects of cell therapy operations, including people, process, and material flow, in compliance with global regulatory requirements.

The RoslinCT Boston Operations Command Center monitors logistics and production activities in real-time, while sophisticated software platforms facilitate data transfer, reduce errors, and enable electronic batch records for real-time testing and product release.